Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.

Regulation and review of DNA vaccine products.

Smith HA.

Dev Biol (Basel). 2000;104:57-62.

PMID:
11713825
2.

Assuring the quality, safety, and efficacy of DNA vaccines.

Robertson JS, Griffiths E.

Mol Biotechnol. 2001 Feb;17(2):143-9. Review.

PMID:
11395863
3.
4.

Assuring the quality, safety, and efficacy of DNA vaccines.

Robertson JS, Griffiths E.

Methods Mol Med. 2006;127:363-74. Review.

PMID:
16988466
5.

The regulation of DNA vaccines.

Smith HA, Klinman DM.

Curr Opin Biotechnol. 2001 Jun;12(3):299-303. Review.

PMID:
11404109
6.

Preclinical and clinical safety studies on DNA vaccines.

Schalk JA, Mooi FR, Berbers GA, van Aerts LA, Ovelgönne H, Kimman TG.

Hum Vaccin. 2006 Mar-Apr;2(2):45-53. Epub 2006 Mar 16. Review.

PMID:
17012886
7.
8.

[Present and future of vaccines].

Oya A.

Rinsho Byori. 2001 Jul;49(7):667-8. Review. Japanese.

PMID:
11519127
9.

Development and standardisation of DNA vaccines.

Cichutek K.

Dev Biol Stand. 1999;100:119-29. Review. No abstract available.

PMID:
10616182
10.

DNA vaccine.

Cui Z.

Adv Genet. 2005;54:257-89. Review.

PMID:
16096015
11.

Recent advances in the development of HIV-1 Tat-based vaccines.

Caputo A, Gavioli R, Ensoli B.

Curr HIV Res. 2004 Oct;2(4):357-76. Review.

PMID:
15544457
12.

Vaccine INDs: review of clinical holds.

Miller DL, Ross JJ.

Vaccine. 2005 Jan 19;23(9):1099-101. Review.

PMID:
15629351
13.

Clinical development of microbicides for the prevention of HIV infection.

D'Cruz OJ, Uckun FM.

Curr Pharm Des. 2004;10(3):315-36. Review.

PMID:
14754390
14.

Current regulatory issues in cell and tissue therapy.

Burger SR.

Cytotherapy. 2003;5(4):289-98. Review.

PMID:
12944234
15.

Exploratory IND: a new regulatory strategy for early clinical drug development in the United States.

Sarapa N.

Ernst Schering Res Found Workshop. 2007;(59):151-63. Review.

PMID:
17117721
16.

Application of PCR technology in vaccine product development.

Wolf JJ, Wang L, Wang F.

Expert Rev Vaccines. 2007 Aug;6(4):547-58. Review.

PMID:
17669009
17.

Drug metabolites in safety testing.

Baillie TA, Cayen MN, Fouda H, Gerson RJ, Green JD, Grossman SJ, Klunk LJ, LeBlanc B, Perkins DG, Shipley LA.

Toxicol Appl Pharmacol. 2002 Aug 1;182(3):188-96. Review.

PMID:
12229863
18.

Regulatory considerations in vaccine design.

Davenport LW.

Pharm Biotechnol. 1995;6:81-96. Review.

PMID:
7551250
20.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920

Supplemental Content

Support Center